COIN vs LAB · P/E 64, rev $7.18B vs rev $174.4M
Coinbase Global Inc (COIN) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Coinbase Global Inc (COIN) is a financial data & stock exchanges company listed on US. It is led by Brian Armstrong.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported COIN revenue for 2025-12-31 was $7.18B. Net income was $1.26B. Revenue was up 9.4% from 2024-12-31 to 2025-12-31. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
COIN currently screens at market cap $45.84B and trailing P/E 64.2. LAB currently screens at market cap $317.1M.
Not investment advice. Open the COIN and LAB stock pages for the full models.
Not investment advice.